AROA Biosurgery Completes Randomised Controlled Trial for Symphony™; Preliminary Read-Out indicates Primary Endpoint Met
Go back to AROA Biosurgery Completes Randomised Controlled Trial for Symphony™; Preliminary Read-Out indicates Primary Endpoint Met| AEROFLEX HOLDING CORP. (NYSE: ARX) | Delayed: 13.25 +0.26 (2.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.99 | 52 Week High | $10.95 | |||
| Open | $13.12 | 52 Week Low | $6.70 | |||
| Day High | $13.67 | P/E | N/A | |||
| Day Low | $12.95 | EPS | $-1.11 | |||
| Volume | 424,759 | |||||
